Hvis ALAT niveauet stiger til > 3 gange den øvre normalgrænse under behandling med rosiglitazon, bør leverenzymerne kontrolleres igen så hurtigt som muligt.
If ALT levels are increased to > 3X upper limit of normal during rosiglitazone therapy, liver enzyme levels should be reassessed as soon as possible.